[Postoperative prognosis of lung cancer].
Explore the source record for details and available documents.
Adenocarcinoma↗
Biomedical subjects
T Naruke
Publications and source records attributed to T Naruke.
[Consideration on lymph node metastases in resectable lung cancer and its indications for surgery].
Explore the source record for details and available documents.
Humans↗
Comparative study of survival of screen-detected compared with symptom-detected lung cancer cases. Japanese Lung Cancer Screening Research Group.
Survival rates were studied in 1,297 screen-detected and 1297 symptom-detected patients with lung cancer. Resections took place in 20 hospitals and institutions in the Japanese Lung Cancer Screening Research Group. 60.6% of the screen-detected lung cancer patients were from stage 0 to 11 and 39.4% were from stage III and IV. On the other hand, 27.1% of symptom-detected patients were from stage 0 to 11 and 72.9% were stage III to IV. In the screen-detected group, the tumor was peripheral in 83%, adenocarcinoma in 52.4% and the resectability rate was 66.5%. Five- and 10-year survival rates were 32.4% and 22.5% respectively in the screen-detected patients and 13.7% and 9.9% in symptom-detected patients.
Aged↗
Studies on new nicotinic acid ester derivatives. 6. Serum cholesterol level lowering effect of 2,2,6,6-tetrakis(nicotinoyloxymethyl) cyclohexanol (K-31).
Explore the source record for details and available documents.
Animals↗